Breast Cancer Research and Treatment

, Volume 77, Issue 1, pp 37–48 | Cite as

Cell Proliferation, Apoptosis, and Expression of Bcl-2 and Bax in Non-Lactating Human Breast Epithelium in Relation to the Menstrual Cycle and Reproductive History

  • F. Feuerhake
  • W. Sigg
  • E.A. Höfter
  • P. Unterberger
  • U. Welsch


Cell proliferation, apoptosis, and the expression of Bcl-2 and Bax were investigated in breast tissue of healthy premenopausal women in order to study the effect of the menstrual cycle and reproductive history on the cell turnover in the non-lactating mammary gland epithelium. Immunohistochemistry was used to detect the proliferation-associated antigen Ki-67, as well as Bcl-2 and Bax. Apoptotic cells were identified by enzymatic labelling of fragmentized DNA (TUNEL-technique) and morphologic analysis. Consistent with published data, the proliferative activity and the frequency of apoptotic events as detected by morphologic analysis was higher in the luteal than in the follicular phase of the menstrual cycle. Parity, lactation, and age correlated with lower proliferative activity, whereas the frequency of apoptosis was not significantly influenced by the reproductive history. Staining patterns for Bax and Bcl-2 showed characteristic changes due to the menstrual cycle with a maximum of immunoreactivity for Bcl-2 in the follicular phase and for Bax in the luteal phase. However, there was no statistically significant association between Bcl-2/Bax immunoreactivity and menstrual cycle or reproductive parameters. We conclude that other molecular pathways than the Bax/Bcl-2 antagonism may additionally be involved in the regulation of apoptotic cell death in the breast epithelium. Knowledge of the entire complexity of apoptosis regulation is necessary to understand the observed effects of parity and lactation on mammary epithelial biology, and possibly to be able to influence pathological processes caused by an imbalance between cell renewal and elimination.

apoptosis Bax Bcl-2 human Ki-67 resting mammary gland TUNEL 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ferguson DJ, Anderson TJ: Morphological evaluation of cell turnover in relation to the menstrual cycle in the ‘resting’ human breast. Br J Cancer 44: 177-181, 1981Google Scholar
  2. 2.
    Ferguson DJ: An ultrastructural study of mitosis and cytokinesis in normal ‘resting’ human breast. Cell Tissue Res 252: 581-587, 1988Google Scholar
  3. 3.
    Anderson TJ, Battersby S, King RJ, McPherson K, Going JJ: Oral contraceptive use influences resting breast proliferation. Hum Pathol 20: 1139-1144, 1989Google Scholar
  4. 4.
    Olsson H, Jernstrom H, Alm P, Kreipe H, Ingvar C, Jonsson P-E, Ryden S: Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res Treat 40: 187-196, 1996Google Scholar
  5. 5.
    Soderqvist G, Isaksson E, von Schoultz B, Carlstrom K, Tani E, Skoog L: Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 176: 123-128, 1997Google Scholar
  6. 6.
    Merlo GR, Cella N, Hynes NE: Apoptosis is accompanied by changes in Bcl-2 and Bax expression, induced loss of attachment, and inhibited by specific extracellular matrix proteins in mammary epithelial cells. Cell Growth Differ 8: 251-260, 1997Google Scholar
  7. 7.
    Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC: Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145: 1323-1336, 1994Google Scholar
  8. 8.
    Reed JC: Balancing cell life and death: Bax, apoptosis and breast cancer. J Clin Invest 97: 2403-2404, 1996Google Scholar
  9. 9.
    Hockenbery DM: Bcl-2 in cancer, development and apoptosis. J Cell Sci Suppl 18: 51-55, 1994Google Scholar
  10. 10.
    Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993Google Scholar
  11. 11.
    Yin XM, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323, 1994Google Scholar
  12. 12.
    Feuerhake F, Sigg W, Hofter EA, Dimpfl T, Welsch U: Immunohistochemical analysis of Bcl-2 and Bax expression in relation to cell turnover and epithelial differentiation markers in the non-lactating human mammary gland epithelium. Cell Tissue Res 299: 47-58, 2000Google Scholar
  13. 13.
    Ferrieres G, Cuny M, Simony-Lafontaine J, Jaquemier J, Rouleau C, Guilleux F, Grenier J, Rouanet P, Pujol H, Jeanteur P, Escot C: Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas. J Pathol 183: 204-211, 1997Google Scholar
  14. 14.
    Sabourin JC, Martin A, Baruch J, Truc JB, Gompel A, Poitout P: Bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer 59: 1-6, 1994Google Scholar
  15. 15.
    Anderson TJ, Ferguson DJ, Raab GM: Cell turnover in the ‘resting’ human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 46: 376-382, 1982Google Scholar
  16. 16.
    Going JJ, Anderson TJ, Battersby S, MacIntyre CC: Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130: 193-204, 1988Google Scholar
  17. 17.
    Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M, Howell A: The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58: 163-170, 1988Google Scholar
  18. 18.
    Bai M, Agnatis NJ, Kamina S, Demou A, Zagorianakou P, Katsaraki A, Kanavaros P: In vivo cell kinetics in breast carcinogenesis. Breast Cancer Res 3: 276-283, 2001Google Scholar
  19. 19.
    Colditz GA, Rosner B: Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 152: 950-964, 2000Google Scholar
  20. 20.
    MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S: Age at first birth and breast cancer risk. Bull World Health Organ 43: 209-221, 1970Google Scholar
  21. 21.
    Chie WC, Hsieh C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Titus-Ernstoff L, Trentham-Dietz A, MacMahon B: Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151: 715-722, 2000Google Scholar
  22. 22.
    Newcomb PA, Sorer BE, Longnecker MP, Mittendorf R, Greenberg R, Clapp RW, Burke KP, Willet WC, MacMahon B: Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330: 81-87, 1994Google Scholar
  23. 23.
    Zheng T, Duan L, Zhang B, Wang Y, Chen Y, Zhang Y, Owens PH: Lactation reduces breast cancer risk in Shandong Province, China. Am J Epidemiol 152: 1129-1135, 2000Google Scholar
  24. 24.
    Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S: Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci USA 98: 11,755-11,759, 2001Google Scholar
  25. 25.
    Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S: Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 96: 2520-2525, 1999Google Scholar
  26. 26.
    Potten CS: What is an apoptotic index measuring? A commentary. Br J Cancer 74: 1743-1748, 1996Google Scholar
  27. 27.
    Strange R, Metcalfe T, Thackray L, Dang M: Apoptosis in normal and neoplastic mammary gland development. Microsc Res Tech 52: 171-181, 2001Google Scholar
  28. 28.
    Chepko G, Smith GH: Three division-competent, structurallydistinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell 29: 239-253, 1997Google Scholar
  29. 29.
    Stirling JW, Chandler JA: The fine structure of ducts and subareolar ducts in the resting gland of the female breast. Virchows Arch A Pathol Anat Histol 373: 119-132, 1977Google Scholar
  30. 30.
    Stirling JW, Chandler JA: The fine structure of the normal, resting terminal ductal-lobular unit of the female breast. Virchows Arch A Pathol Anat Histol 372: 205-226, 1976Google Scholar
  31. 31.
    Song J, Sapi E, Brown W, Nilsen J, Tartaro K, Kacinski BM, Craft J, Naftolin F, Mor G: Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest 106: 1209-1220, 2000Google Scholar
  32. 32.
    Reimer T, Herrnring C, Koczan D, Richter D, Gerber B, Kabelitz D, Friese K, Thiesen H-J: FasL:Fas ratio-a prognostic factor in breast carcinomas. Cancer Res 60: 822-828, 2000Google Scholar
  33. 33.
    Herrnring C, Reimer T, Jeschke U, Makovitzki J, Kruger K, Gerber B, Kabelitz D, Friese K: Expression of the apoptosisinducing ligands FasL and TRAIL in malignant and benign human breast tumors. Histochem Cell Biol 113: 189-194, 2000Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • F. Feuerhake
    • 1
  • W. Sigg
    • 2
  • E.A. Höfter
    • 3
  • P. Unterberger
    • 2
  • U. Welsch
    • 2
  1. 1.University of FreiburgFreiburgGermany
  2. 2.Anatomische Anstalt, Microscopic AnatomyUniversity of MunichMunichGermany
  3. 3.Department of Plastic SurgeryCity Hospital München-BogenhausenMunichGermany

Personalised recommendations